Galaxy
Payments companies reported to CMS as associated with Galaxy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Galaxy, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Galaxy
These are the largest totals companies reported as associated with Galaxy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Amit Mahajan | Falls Church, VA | Internal Medicine | $371,530.20 |
| Douglas Hogarth | Chicago, IL | Pulmonary Disease | $312,287.19 |
| Sean Callahan | Greenville, SC | Pulmonary Disease | $246,063.20 |
| Krishnendu Bhadra | Chattanooga, TN | Pulmonary Disease | $245,932.20 |
| Joseph Cicenia | Cleveland, OH | Pulmonary Disease | $235,302.75 |
| Stephen Kovacs | Erie, PA | Pulmonary Disease | $204,228.11 |
| Sonali Sethi | New York, NY | Pulmonary Disease | $161,824.23 |
| Pravachan Hegde | Clovis, CA | Pulmonary Disease | $34,122.50 |
| Saiyad Sarkar | Baltimore, MD | Pulmonary Disease | $16,120.09 |
| Roshen Mathew | Huntsville, AL | Pulmonary Disease | $11,274.38 |
Prescribed Galaxy?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.